These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 22397670)

  • 21. Thrombocytosis.
    Skoda RC
    Hematology Am Soc Hematol Educ Program; 2009; ():159-67. PubMed ID: 20008195
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of isolated germline JAK2V617I mutation on human hematopoiesis.
    Mead AJ; Chowdhury O; Pecquet C; Dusa A; Woll P; Atkinson D; Burns A; Score J; Rugless M; Clifford R; Moule S; Bienz N; Vyas P; Cross N; Gale RE; Henderson S; Constantinescu SN; Schuh A; Jacobsen SE
    Blood; 2013 May; 121(20):4156-65. PubMed ID: 23535062
    [TBL] [Abstract][Full Text] [Related]  

  • 23. JAK2 exon 12 mutation in myelodysplastic/myeloproliferative neoplasm with ring sideroblasts and thrombocytosis: Not an exclusive mutation to polycythaemia vera.
    Inano T; Araki M; Morishita S; Imai M; Yasuda H; Nitta H; Ito M; Edahiro Y; Ochiai T; Misawa K; Fukuda Y; Ohsaka A; Komatsu N
    Br J Haematol; 2019 Oct; 187(1):e27-e31. PubMed ID: 31418453
    [No Abstract]   [Full Text] [Related]  

  • 24. JAK2/CALR/SF3B1 triple-mutated myelodysplastic/myeloproliferative neoplasm with ring sideroblasts and thrombocytosis evolving to myelofibrosis and SF3B1 single-mutated acute myeloid leukemia: Evidence of a pre-JAK2 clone.
    Yasuda H; Morishita S; Mori Y; Tsukune Y; Inano T; Harada S; Komatsu N
    Leuk Res; 2021 Jan; 100():106496. PubMed ID: 33373831
    [No Abstract]   [Full Text] [Related]  

  • 25. Clonal evolution in hereditary thrombocytosis with MPL T487A mutation.
    Vasseur L; Favier R; Kim R; Rabian F; Cabannes-Hamy A; Cassinat B; Maslah N; Vasquez N; Clappier E; Kiladjian JJ; Boissel N
    Pediatr Blood Cancer; 2023 Feb; 70(2):e29905. PubMed ID: 35924408
    [No Abstract]   [Full Text] [Related]  

  • 26. Narrative review: Thrombocytosis, polycythemia vera, and JAK2 mutations: The phenotypic mimicry of chronic myeloproliferation.
    Spivak JL
    Ann Intern Med; 2010 Mar; 152(5):300-6. PubMed ID: 20194236
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [JAK2(V617F) mutation in Korean patients with essential thrombocythemia].
    Ahn JY; Yoo SJ; Bang SM; Park PW; Seo YH; Shin DB; Lee JH
    Korean J Lab Med; 2007 Apr; 27(2):77-82. PubMed ID: 18094555
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Refractory anemia with ringed sideroblasts associated with thrombocytosis: comparative analysis of marked with non-marked thrombocytosis, and relationship with JAK2 V617F mutational status.
    Raya JM; Arenillas L; Domingo A; Bellosillo B; Gutiérrez G; Luño E; Piñán MA; Barbón M; Pérez-Sirvent ML; Muruzábal MJ; Yánez L; García L; Lemes A; Navarro JT; Elosegi A; Cortés MA; Villegas A; Durán MA; Ardanaz M; Florensa L;
    Int J Hematol; 2008 Nov; 88(4):387-395. PubMed ID: 18820995
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A novel activating, germline JAK2 mutation, JAK2R564Q, causes familial essential thrombocytosis.
    Etheridge SL; Cosgrove ME; Sangkhae V; Corbo LM; Roh ME; Seeliger MA; Chan EL; Hitchcock IS
    Blood; 2014 Feb; 123(7):1059-68. PubMed ID: 24381227
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serial analysis of JAK2 mutation in a patient who developed essential thrombocythemia after orthotopic liver transplantation.
    Au WY; Fung A; Liu CL; Fan ST; Ma SK; Liang R; Kwong YL
    Am J Hematol; 2006 Nov; 81(11):880-2. PubMed ID: 16929538
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Thrombocytosis in children and adolescents-classification, diagnostic approach, and clinical management.
    Stockklausner C; Duffert CM; Cario H; Knöfler R; Streif W; Kulozik AE;
    Ann Hematol; 2021 Jul; 100(7):1647-1665. PubMed ID: 33712866
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Absence of JAK2V617F mutation in patients with beta-thalassemia major and thrombocytosis due to splenectomy.
    Vlachaki E; Kalogeridis A; Neokleous N; Perifanis V; Klonizakis F; Ioannidou E; Klonizakis I
    Mol Biol Rep; 2012 May; 39(5):6101-5. PubMed ID: 22203487
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of MPL K39N and R102P heterozygous germline mutations lead to hereditary thrombocytosis.
    Voirin E; Bouvier A; Plo I; Durix L; Beucher A; Giraudier S; Ugo V; Brasme JF; Luque Paz D
    Am J Hematol; 2024 Aug; 99(8):1644-1646. PubMed ID: 38752375
    [No Abstract]   [Full Text] [Related]  

  • 34. Refractory anemia with ringed sideroblasts and thrombocytosis without JAK2 V617F mutation: report of three cases.
    Tatic A; Vasilică M; Coliţă A; Vasilache D; Dobrea C; Jardan C; Găman AM; Crişan AM; Coliţă D; Coriu D
    Rom J Morphol Embryol; 2013; 54(4):1177-82. PubMed ID: 24399021
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A thrombocytosis occurring in Philadelphia positive CML in molecular response to imatinib can reveal an underlying JAK2(V617F) myeloproliferative neoplasm.
    Véronèse L; Tchirkov A; Richard-Pebrel C; Ledoux-Pilon A; Fleury J; Chaleteix C; Goumy C; Gouas L; Berger MG; Vago P; Bay JO; Tournilhac O
    Leuk Res; 2010 Apr; 34(4):e94-6. PubMed ID: 19833389
    [No Abstract]   [Full Text] [Related]  

  • 36. Undiagnosed myeloproliferative disease in cases of intra-abdominal thrombosis: the utility of the JAK2 617F mutation.
    P'ng S; Carnley B; Baker R; Kontorinis N; Cheng W
    Clin Gastroenterol Hepatol; 2008 Apr; 6(4):472-5. PubMed ID: 18328792
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cooperation of germ line JAK2 mutations E846D and R1063H in hereditary erythrocytosis with megakaryocytic atypia.
    Kapralova K; Horvathova M; Pecquet C; Fialova Kucerova J; Pospisilova D; Leroy E; Kralova B; Milosevic Feenstra JD; Schischlik F; Kralovics R; Constantinescu SN; Divoky V
    Blood; 2016 Sep; 128(10):1418-23. PubMed ID: 27389715
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalence of the frequency of JAK2 (V617F) mutation in different myeloproliferative disorders in Egyptian patients.
    Ebid GT; Ghareeb M; Salaheldin O; Kamel MM
    Int J Clin Exp Pathol; 2015; 8(9):11555-9. PubMed ID: 26617890
    [TBL] [Abstract][Full Text] [Related]  

  • 39. JAK2 V617F mutation is uncommon in patients with the 3q21q26 syndrome.
    Lin P; Luthra R; Nussenzveig RH; Medeiros LJ
    Hum Pathol; 2010 May; 41(5):758-62. PubMed ID: 20153505
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Derivative (1)t(1;19)(p13;p13) in the setting of myelofibrosis with JAK2 V617F.
    Staropoli JF; Wadleigh M; Dal Cin P
    Cancer Genet Cytogenet; 2009 Jun; 191(2):109-10. PubMed ID: 19446748
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.